Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

Researchers created early-stage hair-like structures from skin cells, showing how these cells can self-organize, but more is needed for complete hair growth.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

The study concludes that Twenty-nail dystrophy is more common in boys among children and in women among adults, with varying response to treatment.

Burn scars form abnormally due to changes in wound healing, and more research is needed to improve treatments.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

The document concludes that mouse models are helpful but have limitations for skin wound healing research, and suggests using larger animals and genetically modified mice for better human application.

The document concludes that dandruff and seborrheic dermatitis are linked to inflammation and skin changes, and treating them with specific shampoos can reduce these issues.

The document concludes that understanding hair and feather regeneration can help develop new regenerative medicine strategies.

Alopecia Areata might be linked to Crohn's disease.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Adalimumab helped control a child's severe eye disease when other treatments failed.

The African spiny mouse heals skin without scarring due to different protein activity compared to the common house mouse, which heals with scarring.

Changes in the HR gene have influenced hair growth and may lead to hair loss conditions in humans.

Some patients with Alopecia Areata experience itch due to immune cells and enzymes that cause itching.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Susan Lee Lindquist was a pioneering biologist who made significant contributions to understanding protein folding and its role in disease.

Finasteride may cause gum problems, but stopping the drug can improve these issues.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Hidradenitis suppurativa, a chronic skin disease, can be managed with antibiotics, lifestyle changes, and in severe cases, surgery. Early diagnosis and careful planning are key, and laser treatment can be an efficient solution for mild to severe cases.

Chitosan nanofiber scaffolds improve skin healing and are promising for wound treatment.

Peptide hydrogels heal burn wounds faster and better than standard dressings.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Hair grows faster in the morning and is more vulnerable to damage from radiation due to the internal clock in hair follicle cells.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Low-oxygen conditions and ECM degradation products increase the healing abilities of perivascular stem cells.